Search results for "Heart failure"


 
Results 61 - 70 of about 462 for "Heart failure".
Sort by: Relevance | Newest | Oldest

Changes, challenges in treating heart failure

Readmissions among heart failure patients can be prevented with diligent, evidence-based primary care. But with their time at a premium, physicians can be increasingly concerned about meeting the needs of this population.
https://immattersacp.org/archives/2016/02/heart-failure.htm
1 Feb 2016

Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial

Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2023

Evidence does not support giving renin angiotensin system inhibitors to all patients with stable CAD, review finds

For all primary outcomes studied, renin angiotensin system inhibitors reduced risk when compared to placebo but not when compared to active controls, a study found.
https://immattersacp.org/weekly/archives/2017/01/31/5.htm
31 Jan 2017

Drug interaction risks appear common among older patients being treated for epilepsy

Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018

LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use

Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018

Combat cardiac risks of cancer therapies

One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018

Work toward equity in Black men's health

An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
https://immattersacp.org/archives/2023/07/work-toward-equity-in-black-mens-health.htm
1 Jul 2023

Low-dose aspirin not associated with improved outcomes in heart failure without afib

A total of 5,450 patients were using low-dose aspirin at baseline, and of these, 3,840 were propensity-matched to nonaspirin users in a 1:1 ratio.
https://immattersacp.org/weekly/archives/2018/02/06/5.htm
6 Feb 2018

MKSAP Quiz: Evaluation for β-thalassemia intermedia

A 35-year-old man is evaluated during a routine visit for β-thalassemia intermedia. One year ago, he began requiring erythrocyte transfusions every 4 to 6 months for symptomatic anemia. He has no other symptoms or medical problems, and his only medication is folic acid. Following a physical exam and lab studies, what is the most appropriate additional management?
https://immattersacp.org/weekly/archives/2023/09/12/3.htm
12 Sep 2023

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next